Skip to main content

Table 2 Comparisons of Malignant and Benign Patients

From: Relationship between plasma Atherogenic index and final pathology of Bosniak III-IV renal masses: a retrospective, single-center study

 

Malignancy

 

Malignant

(n = 145, 85.8%)

Benign

(n = 24, 14.2%)

p

Age (year)

median (min-max)

61 (33–84)

63 (39–76)

a0.472

Gender (n, %)

Male

98 (89.9)

11 (10.1)

b0.039*

Female

47 (78.3)

13 (21.7)

Side (n, %)

Right

73 (86.9)

11 (13.1)

b0.682

Left

72 (84.7)

13 (15.3)

Size (cm)

median (min-max)

8 (2–18)

5 (3–11)

a0.223

Localization (n, %)

Lower Pole

23 (88.5)

3 (11.5)

b0.848

Middle Pole

82 (84.5)

15 (15.5)

Upper Pole

40 (87.0)

6 (13.0)

Smoking Status (n, %)

Exist

105 (90.5)

11 (9.5)

b0.009**

None

40 (75.5)

13 (24.5)

Diabetes Mellitus (n, %)

Exist

57 (85.1%)

10 (14.9%)

b0.827

None

88 (86.3%)

14 (13.7%)

Hypertension (n, %)

Exist

95 (90.5%)

10 (9.5%)

b0.026*

None

50 (78.1%)

14 (21.9%)

Body Mass Index (kg/m2)

mean ± SD

29.30 ± 4.36

27.16 ± 3.27

c0.023*

Triglyceride Value [mg/dl]

median (min-max)

156 (68–1019)

164 (100–226)

a0.383

HDL-Cholesterole Value [mg/dl]

mean ± SD

39.64 ± 11.53

50.04 ± 10.59

c0.001**

Plasma Atherogenic Index Value

median (min-max)

0.63 (0.34–1.58)

0.62 (0.39–0.76

a0.003**

  1. aMann Whitney U Test, bPearson Chi-Square Test, cStudent-t Test, *p < 0.05 **p < 0.01